
Savitha M. Rao
Examiner (ID: 10492, Phone: (571)270-5315 , Office: P/1621 )
| Most Active Art Unit | 1629 |
| Art Unit(s) | 1629, 1614, 1621, 1691, 4131 |
| Total Applications | 1525 |
| Issued Applications | 872 |
| Pending Applications | 108 |
| Abandoned Applications | 583 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7523112
[patent_doc_number] => 08026268
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-09-27
[patent_title] => 'Method for scavenging radicals with urocanic acid, derivatives and analogues'
[patent_app_type] => utility
[patent_app_number] => 11/289237
[patent_app_country] => US
[patent_app_date] => 2005-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 8
[patent_no_of_words] => 8534
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/026/08026268.pdf
[firstpage_image] =>[orig_patent_app_number] => 11289237
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/289237 | Method for scavenging radicals with urocanic acid, derivatives and analogues | Nov 28, 2005 | Issued |
Array
(
[id] => 4827152
[patent_doc_number] => 20080125495
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-29
[patent_title] => 'Ameliorant For Renal Insufficiency'
[patent_app_type] => utility
[patent_app_number] => 11/720125
[patent_app_country] => US
[patent_app_date] => 2005-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2205
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0125/20080125495.pdf
[firstpage_image] =>[orig_patent_app_number] => 11720125
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/720125 | Ameliorant For Renal Insufficiency | Nov 24, 2005 | Abandoned |
Array
(
[id] => 5095149
[patent_doc_number] => 20070116758
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-24
[patent_title] => 'Atorvastatin formulation'
[patent_app_type] => utility
[patent_app_number] => 11/285961
[patent_app_country] => US
[patent_app_date] => 2005-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5513
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0116/20070116758.pdf
[firstpage_image] =>[orig_patent_app_number] => 11285961
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/285961 | Atorvastatin formulation | Nov 22, 2005 | Abandoned |
Array
(
[id] => 5546744
[patent_doc_number] => 20090156621
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-18
[patent_title] => 'HCV INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 11/719903
[patent_app_country] => US
[patent_app_date] => 2005-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17190
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0156/20090156621.pdf
[firstpage_image] =>[orig_patent_app_number] => 11719903
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/719903 | HCV INHIBITORS | Nov 13, 2005 | Abandoned |
Array
(
[id] => 4705236
[patent_doc_number] => 20080064760
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-13
[patent_title] => 'Spontaneously Dispersible Pharmaceutical Composition'
[patent_app_type] => utility
[patent_app_number] => 11/575203
[patent_app_country] => US
[patent_app_date] => 2005-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7794
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0064/20080064760.pdf
[firstpage_image] =>[orig_patent_app_number] => 11575203
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/575203 | Spontaneously Dispersible Pharmaceutical Composition | Oct 26, 2005 | Abandoned |
Array
(
[id] => 5807304
[patent_doc_number] => 20060093658
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-04
[patent_title] => 'Apparatus and method for transdermal delivery of desmopressin'
[patent_app_type] => utility
[patent_app_number] => 11/259010
[patent_app_country] => US
[patent_app_date] => 2005-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 14811
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0093/20060093658.pdf
[firstpage_image] =>[orig_patent_app_number] => 11259010
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/259010 | Apparatus and method for transdermal delivery of desmopressin | Oct 24, 2005 | Abandoned |
Array
(
[id] => 5386355
[patent_doc_number] => 20090227600
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-10
[patent_title] => '4-(PYRAZINE-2-YL) -PYRROLIDINE -2-CARBOXYLIC ACID COMPOUNDS AND DERIVATIVES THEREOF AS HEPATITIS C VIRUS INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 11/577940
[patent_app_country] => US
[patent_app_date] => 2005-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18101
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0227/20090227600.pdf
[firstpage_image] =>[orig_patent_app_number] => 11577940
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/577940 | 4-(PYRAZINE-2-YL) -PYRROLIDINE -2-CARBOXYLIC ACID COMPOUNDS AND DERIVATIVES THEREOF AS HEPATITIS C VIRUS INHIBITORS | Oct 23, 2005 | Abandoned |
Array
(
[id] => 5912269
[patent_doc_number] => 20060127331
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-15
[patent_title] => 'Moisturizing compositions'
[patent_app_type] => utility
[patent_app_number] => 11/251939
[patent_app_country] => US
[patent_app_date] => 2005-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5612
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0127/20060127331.pdf
[firstpage_image] =>[orig_patent_app_number] => 11251939
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/251939 | Moisturizing compositions | Oct 17, 2005 | Abandoned |
Array
(
[id] => 5747421
[patent_doc_number] => 20060110352
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-25
[patent_title] => 'Cosmetic, pharmaceutical and dermatological compositions'
[patent_app_type] => utility
[patent_app_number] => 11/250756
[patent_app_country] => US
[patent_app_date] => 2005-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15823
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20060110352.pdf
[firstpage_image] =>[orig_patent_app_number] => 11250756
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/250756 | Cosmetic, pharmaceutical and dermatological compositions | Oct 13, 2005 | Abandoned |
Array
(
[id] => 4711638
[patent_doc_number] => 20080300164
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-04
[patent_title] => 'Calixarene-Based Peptide Conformation Mimetics, Methods of Use, and Methods of Making'
[patent_app_type] => utility
[patent_app_number] => 11/664641
[patent_app_country] => US
[patent_app_date] => 2005-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 32057
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0300/20080300164.pdf
[firstpage_image] =>[orig_patent_app_number] => 11664641
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/664641 | Calixarene-based peptide conformation mimetics, methods of use, and methods of making | Oct 3, 2005 | Issued |
Array
(
[id] => 5171248
[patent_doc_number] => 20070071679
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-29
[patent_title] => 'Methylamine risks and treatment of hyperactivity, depression, and alcoholism with epinephrine-N-quinolines'
[patent_app_type] => utility
[patent_app_number] => 11/248498
[patent_app_country] => US
[patent_app_date] => 2005-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9889
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0071/20070071679.pdf
[firstpage_image] =>[orig_patent_app_number] => 11248498
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/248498 | Methylamine risks and treatment of hyperactivity, depression, and alcoholism with epinephrine-N-quinolines | Sep 28, 2005 | Abandoned |
Array
(
[id] => 4752028
[patent_doc_number] => 20080160101
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-03
[patent_title] => 'Composition For Use Against One Or More Pathogens'
[patent_app_type] => utility
[patent_app_number] => 11/663641
[patent_app_country] => US
[patent_app_date] => 2005-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11077
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20080160101.pdf
[firstpage_image] =>[orig_patent_app_number] => 11663641
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/663641 | Compositions for use against one or more pathogens | Sep 22, 2005 | Issued |
Array
(
[id] => 4922641
[patent_doc_number] => 20080070958
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-20
[patent_title] => 'Therapeutic Agent for Keratoconjunctival Disorder'
[patent_app_type] => utility
[patent_app_number] => 11/662233
[patent_app_country] => US
[patent_app_date] => 2005-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2369
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0070/20080070958.pdf
[firstpage_image] =>[orig_patent_app_number] => 11662233
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/662233 | Therapeutic Agent for Keratoconjunctival Disorder | Sep 12, 2005 | Abandoned |
Array
(
[id] => 4670471
[patent_doc_number] => 20080045531
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-21
[patent_title] => 'Anti-inflammatory medicaments'
[patent_app_type] => utility
[patent_app_number] => 11/224750
[patent_app_country] => US
[patent_app_date] => 2005-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 24449
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0045/20080045531.pdf
[firstpage_image] =>[orig_patent_app_number] => 11224750
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/224750 | Anti-inflammatory medicaments | Sep 11, 2005 | Abandoned |
Array
(
[id] => 5148191
[patent_doc_number] => 20070048247
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-01
[patent_title] => 'Deodorizing tablets'
[patent_app_type] => utility
[patent_app_number] => 11/217098
[patent_app_country] => US
[patent_app_date] => 2005-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6627
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20070048247.pdf
[firstpage_image] =>[orig_patent_app_number] => 11217098
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/217098 | Deodorizing tablets | Aug 30, 2005 | Abandoned |
Array
(
[id] => 4999369
[patent_doc_number] => 20070042003
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-22
[patent_title] => 'Method of effecting a mammalian model of sepsis, severe sepsis, or septic shock'
[patent_app_type] => utility
[patent_app_number] => 11/208143
[patent_app_country] => US
[patent_app_date] => 2005-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 11211
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0042/20070042003.pdf
[firstpage_image] =>[orig_patent_app_number] => 11208143
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/208143 | Method of effecting a mammalian model of sepsis, severe sepsis, or septic shock | Aug 18, 2005 | Abandoned |
Array
(
[id] => 92332
[patent_doc_number] => 07732479
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-06-08
[patent_title] => 'Compositions for treating amyloid associated diseases'
[patent_app_type] => utility
[patent_app_number] => 11/660522
[patent_app_country] => US
[patent_app_date] => 2005-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 11
[patent_no_of_words] => 13779
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/732/07732479.pdf
[firstpage_image] =>[orig_patent_app_number] => 11660522
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/660522 | Compositions for treating amyloid associated diseases | Aug 17, 2005 | Issued |
Array
(
[id] => 4887747
[patent_doc_number] => 20080262079
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-23
[patent_title] => 'Cannabinoid Compositions and Methods of Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 11/659751
[patent_app_country] => US
[patent_app_date] => 2005-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5384
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0262/20080262079.pdf
[firstpage_image] =>[orig_patent_app_number] => 11659751
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/659751 | Cannabinoid Compositions and Methods of Use Thereof | Aug 8, 2005 | Abandoned |
Array
(
[id] => 5050942
[patent_doc_number] => 20070031487
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-08
[patent_title] => 'Nutritional supplement for women'
[patent_app_type] => utility
[patent_app_number] => 11/197760
[patent_app_country] => US
[patent_app_date] => 2005-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2882
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0031/20070031487.pdf
[firstpage_image] =>[orig_patent_app_number] => 11197760
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/197760 | Nutritional supplement for women | Aug 3, 2005 | Issued |
Array
(
[id] => 5820059
[patent_doc_number] => 20060024372
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-02
[patent_title] => 'High viscosity antibacterials'
[patent_app_type] => utility
[patent_app_number] => 11/194818
[patent_app_country] => US
[patent_app_date] => 2005-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6902
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0024/20060024372.pdf
[firstpage_image] =>[orig_patent_app_number] => 11194818
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/194818 | High viscosity antibacterials | Jul 31, 2005 | Abandoned |